← All Genetic Counselors on the Network

Krista Savage

she/her
Board-Certified by ABGC
NeurogeneticsCardiovascular GeneticsPharmacogenomics
Krista Savage
M.S., Genetic Counseling, University of Cincinnati, 2014
B.S., Biology, Marquette University, 2011

Krista received her MS in genetic counseling from the University of Cincinnati in 2014 and is board certified. Krista has a deep knowledge and experience in neurogenetics, which began at the University of Texas in Houston, where she worked in the Department of Neurosurgery for over six years. Here, she worked with neurosurgeons and neuro-oncologists and provided genetic counseling for patients with brain aneurysms, cerebral cavernous malformations, and brain tumors. She also started a genetic counseling clinic for adults with a variety of neurogenetic conditions, including hereditary forms of neuropathy, neuromuscular conditions, ataxia, epilepsy, ALS, and dementia.

In 2020, Krista joined Invitae Corporation to provide genetic counseling for patients who had received genetic testing through Invitae. She expanded Invitae’s genetic counseling services to include neurology for the first time, then broadened further to provide genetic counseling across multiple specialties, including cardiology, connective tissue disorders, ophthalmology, immunology, general genetics, whole exome sequencing, and proactive (healthy) genetics.

Krista believes in providing personalized care and creating an environment where any question can be asked, no matter how big or seemingly small. Her priorities are to focus on the areas that are most important to her patients and to help make genetic information approachable and understandable for everyone. She is licensed in all states that have licensure requirements, making her available to speak with patients and family members no matter where they live.

Former employee and current stockholder, Invitae Corporation. Contractor: Synapticure & CareND, My Gene Counsel LLC, SteadyMD Inc., Everly Health Inc.
  • Glaser K & Qualmann K: The ABCs of NDDs. Invitae-sponsored webinar, June 2022.
  • Qualmann KJ: Gene Therapy in Neurogenetics: Spinal Muscular Atrophy. Rice Medical Speaker Conference, January 2020.
  • Qualmann KJ: Genetics and Brain Tumors. Brain Tumor Patient Support Group, Mischer Neuroscience Institute, August 2015 & April 2018.
  • Jackson M, Dunbar EM, Qualmann KJ and Henson JW: Tumor Predisposition and Genetic Risk Assessment in a Neuro-Oncology Practice. Society for Neuro-Oncology Annual Meeting, November 2016.
  • Qualmann KJ: Charcot-Marie Tooth Hereditary Neuropathy. CMT Patient Support Group, Memorial Hermann Hospital, November 2015 & March 2016.
  • Santiago-Sim T and Qualmann KJ: An Update on Brain Aneurysms. Brain Aneurysm Patient Support Group, Mischer Neuroscience Institute, July 2014.
  • View in Google Scholar →  ·  View in PubMed →
Book an Appointment

Initial consultation — 60 minutes by secure video.

Schedule with Krista →
Free 10-minute intro call
Can See Patients In
Licensed in: AL, AR, CA, CT, DE, FL, GA, IA, ID, IL, IN, KY, LA, MA, MD, MI, MN, MS, MT, NV, NE, ND, NH, NJ, NM, OH, OK, OR, PA, RI, SD, TN, UT, VA, WA, WI
AK, AZ, CO, DC, HI, KS, ME, MO, NC, NY, TX, VT, WY
Fees
$275
Initial consult · 60 minutes · Telehealth
$100 — Follow-up, 30 min follow-up
Languages
English